BioCentury
ARTICLE | Targets & Mechanisms

Affibody vs Amyloid

April 1, 2010 7:00 AM UTC

Swedish and British researchers have shown that Affibody AB's Affibodies can be engineered to bind and clear toxic b-amyloid from the brains of fruit flies.1 The academics are now planning to look at the Affibodies in rodent models of Alzheimer's disease.

The biotech is helping by increasing the bioavailability of its lead Affibody for AD, ZAb3, but its focus remains on Affibodies for cancer...